Defunct Company
Total Trials
7
As Lead Sponsor
6
As Collaborator
1
Total Enrollment
219
NCT00567814
A Placebo-Controlled Study of a Combination of Metyrapone and Oxazepam in Cocaine Addiction
Phase: N/A
Role: Lead Sponsor
Start: Dec 31, 2007
Completion: Nov 30, 2008
NCT02406066
Single and Multiple Rising Dose Study of Safety and PK of Metyrapone/Oxazepam Combination (EMB-001)
Phase: Phase 1
Start: Mar 31, 2015
Completion: Jun 30, 2016
NCT02856854
A Study of Metyrapone and Oxazepam Combination Product (EMB-001) and Cocaine
Start: Jul 31, 2016
Completion: Jul 25, 2017
NCT03404817
Single Dose Crossover Comparative Bioavailability and Food Effect Study of Two EMB-001 Formulations
Start: Mar 1, 2018
Completion: Jun 7, 2018
NCT04501874
A Study to Evaluate EMB 001 in Subjects With Cocaine Use Disorder
Phase: Phase 2
Start: Jul 29, 2020
Completion: Oct 15, 2022
NCT04868253
Efficacy and Safety of Combination EMB-001 as a Potential Smoking Cessation Treatment
Phase: Phase 2/3
Role: Collaborator
Start: May 19, 2021
Completion: Dec 31, 2021
NCT04933916
Study of EMB-001 as a Potential Smoking Cessation Treatment
Phase: Phase 1/2
Start: Jun 10, 2021
Completion: May 1, 2023